Applied Genetic Technologies Corporation
Home
•
News
About Us
Overview
Board of Directors
Employees
Management
Contact Us
PRODUCT PROGRESS
Pre-Clinical
Clinical
Contact Us
TECHNOLOGY & RESEARCH
Gene Therapy & AAV
Collaborators
Contact Us
NEWSROOM
Latest News
Contact Us
CAREER OPPORTUNITIES
Overview
Benefits
Current Openings
Contact Us
CONTACT US
Location
Map
Contact Us
AGTC NEWS
11/19/2012
AGTC Secures $37.5M Series B Funding
09/21/2011
A
GTC receives $1.5M from FFB for pre-clinical study
05/25/2011
Sue Washer, AGTC CEO on TV20 Technology Spotlight
09/16/2010
AGTC receives second grant from FDA for clinical study of Genetic Respiratory Disease
09/13/2010
AGTC receives grant from FDA for clinical study of Genetic Retinal Disease
09/07/2010
Bellingham brothers get experimental gene therapy in attempt to save sight
06/24/2010
AGTC and Icagen announce technology transfer agreement
08/04/2009
AGTC on TV20 Technology Spotlight
06/29/2009
AGTC and NNRI Collaborate in two Genetic Retinal Diseases
04/30/2009
AGTC raises $11.8M VC Financing
06/21/2007
AGTC receives $2M milestone from Genzyme
05/16/2006
AGTC & JDRF Announce Partnership to Treat Diabetic Eye Disease
02/23/2006
AGTC Announces Initiation of Phase 1 Clinical Study - Safety of AGTC-0106
12/06/2004
Genzyme, AGTC Announce Gene Therapy Collaboration
Comments or Questions?
Applied Genetic Technologies, Corporation, 11801 Research Drive, Suite D, Alachua, Florida 32615 - 386.462.2204
Nov. 19, 2012